PLoS ONE · 2018 · 33 citations · 46 references
Molecular BiologyNeurochemical BiomarkersSynaptic SignalingBrain InteractomeProteomic TechnologyPrp InteractorsAlzheimer's DiseaseDegenerative PathologyPrion DiseaseProtein MisfoldingBrain PathologyProteomicsMolecular SignalingMolecular NeuroscienceBiochemistryCellular Prion ProteinTranslational ProteomicsBiomolecular EngineeringNeurodegenerative DiseasesScrapie Prion ProteinNatural SciencesN-terminal DomainNeuroscienceMedicineSmall Molecules
The cellular prion protein (PrPC) is implicated in neuroprotective signaling and neurotoxic pathways in both prion diseases and Alzheimer's disease (AD). Specifically, the intrinsically disordered N-terminal domain (N-PrP) has been shown to interact with neurotoxic ligands, such as Aβ and Scrapie prion protein (PrPSc), and to be crucial for the neuroprotective activity of PrPC. To gain further insight into cellular pathways tied to PrP, we analyzed the brain interactome of N-PrP. As a novel approach employing recombinantly expressed PrP and intein-mediated protein ligation, we used N-PrP covalently coupled to beads as a bait for affinity purification. N-PrP beads were incubated with human AD or control brain lysates. N-PrP binding partners were then identified by electrospray ionization tandem mass spectrometry (nano ESI-MS/MS). In addition to newly identified proteins we found many previously described PrP interactors, indicating a crucial role of the intrinsically disordered part of PrP in mediating protein interactions. Moreover, some interactors were found only in either non-AD or AD brain, suggesting aberrant PrPC interactions in the pathogenesis of AD.
46
Synthesis of Proteins by Native Chemical Ligation
Philip E. Dawson, Tom W. Muir, Ian Clark‐Lewis et al. · Science · 1994 · 4.1K citations
Mice devoid of PrP are resistant to scrapie
Hansruedi Büeler, Adriano Aguzzi, Andreas W. Sailer et al. · Cell · 1993 · 2.1K citations · Full text